Cargando…

Editorial: New Drug Targets for Proteotoxicity in Cardiometabolic Diseases

Detalles Bibliográficos
Autores principales:	Ren, Jun, Wang, Xin, Zhang, Yingmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481817/ https://www.ncbi.nlm.nih.gov/pubmed/34603089 http://dx.doi.org/10.3389/fphys.2021.745296

Ejemplares similares

Editorial: Targeting Cardiac Proteotoxicity
por: Ranek, Mark J., et al.
Publicado: (2021)

Targeting Protein Kinase G to Treat Cardiac Proteotoxicity
por: Oeing, Christian U., et al.
Publicado: (2020)

Editorial: Remodeling in cardiometabolic diseases: Towards biomarker characterization, target therapy identification, and drug delivery strategies
por: Ammar, Hania, et al.
Publicado: (2023)

Editorial: The neuroendocrine, autonomic and neuroinflammatory stress axes in cardiometabolic disease
por: Colombari, Débora S. A., et al.
Publicado: (2023)

Editorial: Membrane domains as new drug targets
por: van Spriel, Annemiek B., et al.
Publicado: (2015)

Highly Dynamic Changes in the Activity and Regulation of Macroautophagy in Hearts Subjected to Increased Proteotoxic Stress
por: Pan, Bo, et al.
Publicado: (2019)

Emerging Developments in Targeting Proteotoxicity in Neurodegenerative Diseases
por: McAlary, Luke, et al.
Publicado: (2019)

Proteotoxicity and Neurodegenerative Diseases
por: Ruz, Clara, et al.
Publicado: (2020)

Editorial: Inflammatory Cells in the Sick Heart and Adipose Tissue: Novel Targets for Old and New Drugs
por: Raimondi, Laura, et al.
Publicado: (2021)

Proteotoxic stress targeted therapy (PSTT)
por: Sherman, Michael Y.
Publicado: (2011)

Editorial: Specialized proresolving mediators: Benefits within and beyond inflammation resolution in cardiometabolic, neurological and psychiatric disorders
por: Sousa, Teresa, et al.
Publicado: (2023)

Editorial: Novel Strategies Targeting Obesity and Metabolic Diseases
por: Ma, Xinran, et al.
Publicado: (2019)

Editorial: Metabolism and Vascular Diseases
por: Zhi, Kangkang, et al.
Publicado: (2022)

Editorial: Carotid body: a new target for rescuing neural control of cardiorespiratory balance in disease
por: Del Rio, Rodrigo, et al.
Publicado: (2015)

Developmental Origins of Cardiometabolic Diseases: Role of the Maternal Diet
por: Costa-Silva, João H., et al.
Publicado: (2016)

Autophagic Regulation of Lipid Homeostasis in Cardiometabolic Syndrome
por: Yang, Mingjie, et al.
Publicado: (2018)

Editorial: Stress in health and disease: new era and new challenges
por: Uchakin, Peter N., et al.
Publicado: (2023)

Relaxin-2 in Cardiometabolic Diseases: Mechanisms of Action and Future Perspectives
por: Feijóo-Bandín, Sandra, et al.
Publicado: (2017)

Editorial: Physiological phenotyping in respiratory diseases: New approaches
por: King, G. G., et al.
Publicado: (2023)

Editorial: Targeting innate and adaptive immunity for improvement of cardiovascular disease
por: Janssen, Henrike, et al.
Publicado: (2022)

Circulating Ceramide: A New Cardiometabolic Biomarker in Patients With Comorbid Acute Coronary Syndrome and Type 2 Diabetes Mellitus
por: Cao, Ruihua, et al.
Publicado: (2020)

HIPK2 is a new drug target for anti-fibrosis therapy in kidney disease
por: Nugent, Melinda M., et al.
Publicado: (2015)

Luteolin Attenuates Doxorubicin-Induced Cardiotoxicity Through Promoting Mitochondrial Autophagy
por: Xu, Haixia, et al.
Publicado: (2020)

Proteasome Activation to Combat Proteotoxicity
por: Jones, Corey L., et al.
Publicado: (2019)

Aneuploidy and proteotoxic stress in cancer
por: Donnelly, Neysan, et al.
Publicado: (2015)

Hypothalamic GPCR Signaling Pathways in Cardiometabolic Control
por: Deng, Yue, et al.
Publicado: (2021)

Editorial: New advances in the renal regulation of K(+) homeostasis in health and disease
por: Crambert, Gilles, et al.
Publicado: (2023)

Aquaglyceroporins: Drug Targets for Metabolic Diseases?
por: Calamita, Giuseppe, et al.
Publicado: (2018)

Editorial: Renal Regulation of Water and Sodium in Health and Disease
por: Suh, Sang Heon, et al.
Publicado: (2022)

Editorial: Novel Insights Into Obesity-Related Diseases
por: Zhang, Xiang, et al.
Publicado: (2022)

Editorial: Invertebrate Models of Natural and Drug-Sensitive Reward
por: van Staaden, Moira, et al.
Publicado: (2019)

Editorial: Hepatic glucose and lipid metabolism
por: Zhang, Huabing, et al.
Publicado: (2022)

Editorial: Mitochondrial disorders and cardiovascular diseases
por: Zhang, Quanjiang, et al.
Publicado: (2023)

Editorial: Regulation of Endurance Performance: New Frontiers
por: Hettinga, Florentina J., et al.
Publicado: (2017)

Enhancing proteotoxic stress as an anticancer strategy
por: Grant, Steven
Publicado: (2011)

Glucose delays age-dependent proteotoxicity
por: Tauffenberger, Arnaud, et al.
Publicado: (2012)

Proteostasis and Proteotoxicity in the Network Medicine Era
por: Lualdi, Marta, et al.
Publicado: (2020)

Editorial: Lipid metabolism and human diseases
por: Amadi, Peter U., et al.
Publicado: (2022)

Editorial: Erythrocytes as a target of oxidative stress in blood
por: Remigante, Alessia, et al.
Publicado: (2023)

Defective transcription elongation in human cancers imposes targetable proteotoxic vulnerability
por: Muhammad, B., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vu4pcdgtri178d8vgqipivsikn